Rigel Pharmaceuticals, Inc. is a biotech company focusing on therapies for hematologic disorders and cancer. Analysts predict the company will break even in 2024, with profitability expected in 2025.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing